SecondCor521
Give me a museum and I'll fill it. (Picasso) Give me a forum ...
I think you'll agree there's more to a functional market than that. Consumers have to be able to make a rational estimate of the quality and availability of the services from the various sellers (very hard right now with health care.). They need information to even choose which services to buy (easy if it is "replace my knee joint," harder if it is "eliminate my cancer "). Competition based on best value is also always hampered if time is limited.
I do think that increasing transparency on available options, their cost, and better info on expected outcomes would help lower the cost of health care if patients also were price sensitive. But for a market and pricing signals to work well, they all have to be present.
The issue of how these costs are to be paid is also inter-related.
I'd guess even people with a lot of money would be disinclined to spend it on extreme one-in-a-million end-of-life treatments if it means they'll be spending money that their spouse and kids need. But if unknown others are paying, they'd likely be willing to turn on the money tap and roll the dice If the docs and medical providers make more as a result, I can see some perverse incentives regarding information flow.
I was arguing for the minimal conditions that I thought were necessary to generate competitive downward pressure on price in a market, not what the necessary conditions were for a functional market. I was also mostly disagreeing with the argument of the previous poster that because life is very valuable (which I agree it is) that doctors don't compete on price (which they don't, but I don't think it is for that reason). Supercars and large mansions are extremely expensive (even more than an average Joe's life according to the highway design folks), and yet there is a functioning market for those items.
Time limitations (that are sometimes there and sometimes aren't, to varying degrees) and the fact that health care is complex do indeed make it harder to shop around.
I think your "inter-related" sentence is key. IMO, there are things (government policies, insurance+job interrelations, and maybe some things in the prescription drug part of the market) that interfere with those price signals and the customer's interest in seeking the information.
My understanding is we do spend a lot on end-of-life care in the US. Partly because we don't like to give up - Americans are a generally optimistic lot - but also because usually someone else is paying. If a kidney transplant to save Great Aunt Edna is $100K and government or insurance is paying, then go ahead. If the four grandkids have to write $25K checks, maybe we think she lived a long good life but it's time to let nature and old age take its course.
I like your ideas about transparency and more information.